USA: The use of Impella during the high-risk percutaneous coronary intervention (PCI) led to improved survival and less in-hospital myocardial infarction (MI) and cardiogenic shock compared with an.
China: In patients with acute STEMI, the glycemic gap may predict all-cause mortality and MACE within 30 days, a recent journal Atherosclerosis has found. GAPmean is the difference between mean blood.